Cargando…
Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases
PURPOSE: To assess the effects of different beam starting phases on dosimetric variations in the clinical target volume (CTV) and organs at risk (OARs), and to identify the relationship between plan complexity and the dosimetric impact of interplay effects in volumetric‐modulated arc therapy (VMAT)...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806466/ https://www.ncbi.nlm.nih.gov/pubmed/31539194 http://dx.doi.org/10.1002/acm2.12720 |
_version_ | 1783461633390018560 |
---|---|
author | Sasaki, Makoto Nakamura, Mitsuhiro Mukumoto, Nobutaka Goto, Yoko Ishihara, Yoshitomo Nakata, Manabu Sugimoto, Naozo Mizowaki, Takashi |
author_facet | Sasaki, Makoto Nakamura, Mitsuhiro Mukumoto, Nobutaka Goto, Yoko Ishihara, Yoshitomo Nakata, Manabu Sugimoto, Naozo Mizowaki, Takashi |
author_sort | Sasaki, Makoto |
collection | PubMed |
description | PURPOSE: To assess the effects of different beam starting phases on dosimetric variations in the clinical target volume (CTV) and organs at risk (OARs), and to identify the relationship between plan complexity and the dosimetric impact of interplay effects in volumetric‐modulated arc therapy (VMAT) plans for pancreatic cancer. METHODS: Single and double full‐arc VMAT plans were generated for 11 patients. A dose of 50.4 Gy in 28 fractions was prescribed to cover 50% of the planning target volume. Patient‐specific Digital Imaging and Communications in Medicine–Radiation Therapy plan files were divided into 10 files based on the respiratory phases in four‐dimensional computed tomography (4DCT) simulations. The phase‐divided VMAT plans were calculated in consideration of the beam starting phase for each arc and were then combined in the mid‐ventilation phase of 4DCT (4D plans). The dose‐volumetric parameters were compared with the calculated dose distributions without consideration of the interplay effects (3D plans). Additionally, relationships among plan parameters such as modulation complexity scores, monitor units (MUs), and dose‐volumetric parameters were evaluated. RESULTS: Dosimetric differences in the median values associated with different beam starting phases were within ± 1.0% and ± 0.2% for the CTV and ± 0.5% and ± 0.9% for the OARs during single and double full‐arc VMAT, respectively. Significant differences caused by variations in the beam starting phases were observed only for the dose‐volumetric parameters of the CTV during single full‐arc VMAT (P < 0.05), associated with moderate or strong correlations between the MUs and the dosimetric differences between the 4D and 3D plans. CONCLUSIONS: The beam starting phase affected CTV dosimetric variations of single full‐arc VMAT. The use of double full‐arc VMAT mitigated this problem. However, variation in the dose delivered to OARs was not dependent on the beam starting phase, even for single full‐arc VMAT. |
format | Online Article Text |
id | pubmed-6806466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68064662019-10-28 Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases Sasaki, Makoto Nakamura, Mitsuhiro Mukumoto, Nobutaka Goto, Yoko Ishihara, Yoshitomo Nakata, Manabu Sugimoto, Naozo Mizowaki, Takashi J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: To assess the effects of different beam starting phases on dosimetric variations in the clinical target volume (CTV) and organs at risk (OARs), and to identify the relationship between plan complexity and the dosimetric impact of interplay effects in volumetric‐modulated arc therapy (VMAT) plans for pancreatic cancer. METHODS: Single and double full‐arc VMAT plans were generated for 11 patients. A dose of 50.4 Gy in 28 fractions was prescribed to cover 50% of the planning target volume. Patient‐specific Digital Imaging and Communications in Medicine–Radiation Therapy plan files were divided into 10 files based on the respiratory phases in four‐dimensional computed tomography (4DCT) simulations. The phase‐divided VMAT plans were calculated in consideration of the beam starting phase for each arc and were then combined in the mid‐ventilation phase of 4DCT (4D plans). The dose‐volumetric parameters were compared with the calculated dose distributions without consideration of the interplay effects (3D plans). Additionally, relationships among plan parameters such as modulation complexity scores, monitor units (MUs), and dose‐volumetric parameters were evaluated. RESULTS: Dosimetric differences in the median values associated with different beam starting phases were within ± 1.0% and ± 0.2% for the CTV and ± 0.5% and ± 0.9% for the OARs during single and double full‐arc VMAT, respectively. Significant differences caused by variations in the beam starting phases were observed only for the dose‐volumetric parameters of the CTV during single full‐arc VMAT (P < 0.05), associated with moderate or strong correlations between the MUs and the dosimetric differences between the 4D and 3D plans. CONCLUSIONS: The beam starting phase affected CTV dosimetric variations of single full‐arc VMAT. The use of double full‐arc VMAT mitigated this problem. However, variation in the dose delivered to OARs was not dependent on the beam starting phase, even for single full‐arc VMAT. John Wiley and Sons Inc. 2019-09-20 /pmc/articles/PMC6806466/ /pubmed/31539194 http://dx.doi.org/10.1002/acm2.12720 Text en © 2019 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Sasaki, Makoto Nakamura, Mitsuhiro Mukumoto, Nobutaka Goto, Yoko Ishihara, Yoshitomo Nakata, Manabu Sugimoto, Naozo Mizowaki, Takashi Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases |
title | Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases |
title_full | Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases |
title_fullStr | Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases |
title_full_unstemmed | Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases |
title_short | Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases |
title_sort | variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806466/ https://www.ncbi.nlm.nih.gov/pubmed/31539194 http://dx.doi.org/10.1002/acm2.12720 |
work_keys_str_mv | AT sasakimakoto variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases AT nakamuramitsuhiro variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases AT mukumotonobutaka variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases AT gotoyoko variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases AT ishiharayoshitomo variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases AT nakatamanabu variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases AT sugimotonaozo variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases AT mizowakitakashi variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases |